- 米国企業
- Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc.ANEB
時価総額
$5420万
PER
| 2021年 6月30日 | 2022年 6月30日 | 2023年 6月30日 | |
| Research and development | 2 | 3 | 6 |
| General and administrative | 1 | 4 | 6 |
| Total operating expenses | 4 | 7 | 12 |
| Loss from operations | - | -6,831,174 | -11,783,599 |
| Interest income | - | 7,332 | 92,407 |
| Other | -1,344 | -1,777 | -41,146 |
| Total other income, net | -26,638,801 | 5,555 | 51,261 |
| Net loss | -30,252,554 | -6,825,619 | -11,732,338 |
| Net loss per share, basic | - | -0.29 | 0.47 |
| Net loss per share, diluted | - | - | 0.47 |